INTRODUCTION
============

Orthodontic forces cause an initial inflammatory response followed by alterations in the vascular and neural envelope and perpetual bone and tissue remodelling accompanied by paracrine release of bioactive mediators.[@B1] ^-^ [@B3] During orthodontic tooth movement (OTM), host-derived enzymes are released at various stages of activation, resorption, reversal and deposition of osseous elements and degradation of the extracellular matrix.[@B4] Some of these enzymes have been identified in the periodontal (pdl) tissue of orthodontically moved teeth.^5^ Gingival crevicular fluid (GCF) is however a better choice for assessing biomolecules or mediators as sample collection is simple, sensitive, convenient, repetitive and non-invasive.[@B6] Thus, the quantitative estimations of mediators in GCF reflect biochemical mechanisms associated with OTM. A systematic review (SR) by Kapoor et al[@B6] in 2014 studied variation in GCF level of cytokines with type and magnitude of orthodontic forces and growth status of patients. It established a positive correlation of GCF activity index IL1RA (interleukin receptor antagonist)/ IL-1β) with intensity of pain and velocity of OTM and a negative correlation with growth status of patients. Besides cytokines, numerous other mediators also alter GCF during OTM, comprehensively reviewed in SR by Alhadlaq[@B3] in 2015. This SR highlighted working mechanisms of multiple mediators but heterogeneity of studies precluded attainment of concrete conclusions. Hence, the present SR aims to assess only a single family of mediators, enzymes, to establish their clinical correlations on sequential release in different phases of OTM and varying magnitude of orthodontic forces.

Soluble enzymes like lactate dehydrogenase (LDH) and aspartate aminotransferase (AST) present in cytoplasm are known to release in GCF only after cellular necrosis or hyalinization with heavy orthodontic forces.[@B4] Tartrate-resistant acid phosphatase (TRAP) and alkaline phosphatase (ALP) exhibit osteoclastic and osteoblastic activity, respectively,[@B1] and are identified in areas of tension (TS) or compression (CS) of teeth undergoing OTM. Heavy orthopedic forces of rapid maxillary expansion show an increase of ß-glucuronidase (ßG) lysosomal enzyme upon release from polymorphonuclear (PMN) leukocytes.[@B7] Rise in PMN granules in surrounding tissues after fixed orthodontic appliance activation also show increase in myeloperoxidase (MPO) 2 hours (hr) after activation, traced both in GCF and saliva.[@B8]

The evidence on enzymes in OTM is plenty but scattered and lacks critical appraisal. Hence, the current SR is conducted to establish associations of enzymes in GCF to the site of application, magnitude and type of force, patient's growth status and the type of archwire ligation.

MATERIAL AND METHODS
====================

Protocol and registration
-------------------------

The protocol for SR was registered in PROSPERO (www.crd.york.ac.uk/prospero, CRD42015017496) with a predetermined search strategy ([Fig 1](#f1){ref-type="fig"}). It comprised of MeSH terms, Boolean terminology and free text terms with the keywords \"enzyme\" \"protease\", \"orthodontic tooth movement\" and \"gingival crevicular fluid\", together with several key enzymes. This search strategy was applied to key databases PubMed, Scopus and Embase in February 2018 with no language restrictions. Additional publications were identified through reference tracking and hand search of journals (Sains Malaysiana, Orthodontic Waves, Journal of Applied Sciences, APMC). The search was performed by two reviewers, followed by a cross-check by a third reviewer, in conformity with PRISMA, as shown in [Figure 2](#f2){ref-type="fig"}.

Figure 1Search strategy applied on databases for inclusion of studies in the review.

Figure 2PRISMA flow diagram for inclusion of studies in the systematic review

Evaluation of risk of bias / quality of individual studies
----------------------------------------------------------

The risk of bias, subjective to the included studies was measured by a customized Quality Assessment Instrument (QAI)[@B6] based on QUADAS. This was objectively scored as minimally (scores of 1-12), moderately (13-20) and highly (21-29) sensitive, summarized in [Table 1](#t1){ref-type="table"}. No minimally sensitive studies were included in the review.

Table 1Inclusion and Exclusion criteria applied for inclusion of studies in the systematic review.CriteriaSub criteriaInclusionExclusionParticipants/populationType of sampleHuman studiesAnimal studies, in vitro studiesAge groupsif specifiedNot mentionedMale to female ratioif specifiedNot mentionedControlspresent (either internal /external)No controlsSample size (sample size, not number of teeth studied)≥5\<5Intervention(s), exposure(s)Mediators studiedenzymes \[AST, MPO, ALP,βG, LDH, CatB, Cs, cAMP RII, MMPs\]Other than enzymes (cytokines/ hormones/PGs)ExposureOrthodontic force application in healthy patientsStudied in periodontal inflammation/ root resorption/ not relatedOrthodontic mechanicsSpecifiedNot specifiedOral hygiene regimenMentionedNot mentionedUse of antibiotic/anti-inflammatory drugsNot usedNot mentioned/ usedMedium of studyGCFOther than GCF/ peri-implant fluid/salivaGCF sample collection instrumentPeriopaper/micropipette/ endodontic paperNot mentioned[^2]

RESULTS
=======

Were identified 102 articles in Pubmed, 460 in Scopus, 84 in Embase and 6 from hand search, in the initial search. Strict inclusion and exclusion criteria (Table 2) were applied after removing duplicates, resulting in 41 relevant articles. Five studies were further excluded: three studies whose full texts were not retrieved despite contacting the authors repeatedly through mail and academic social networking sites; one was a review on MMPs, and one had sample size smaller than inclusion criteria. Additional exclusion of three studies was done: two with QAI score smaller than 13, and one with a cross-sectional study design ([Fig 2](#f2){ref-type="fig"}).

Table 2Quality Assessment Instrument (QAI) customized from QUADAS (Quality Assessment of Diagnostic Accuracy Studies) tool for assessment of risk of bias for inclusion of studies in the review.S. No.Criteria (29)ResponseYesNoUnclearI. Study design1.Objective: objective clearly formulated2.Sample size: considered adequate3.Spectrum of patients representative of patients receiving the test in practice4.Ethical clearance mentioned5.Selection criteria: clearly described6.Randomization: stated7.Baseline characteristics: clearly defined8.Control: clearly defined9.Orthodontic mechanics explained in sufficient detail to permit replication of experiment10.Orthodontic force: clearly specified11.Description of execution of index test: sufficient to permit replication of test12Absence of time difference between index test & control: mentioned13.Index test executed at specified time and environmental conditions14.Use of proper indices for assessment of gingival & periodontal status (pre-treatment)15.Use of proper indices for assessment of gingival & periodontal status (at each observation time)16.Oral hygiene regime: mentioned17.Prophylaxis done (pre-treatment)18.Prophylaxis done (at each observation time)II. Study measurements1.GCF handling characteristics: explained2.Measurement method: appropriate to the objective3.Reliability: adequate level of agreementIII. Statistical analysis1.Dropouts: dropouts included in data analysis2.Statistical analysis: appropriate for data3.Confounders: confounders included in analysis4.Statistical significance level: P value stated5.Confidence intervals providedIV. Study results and conclusions (3)1.Index test compared to baseline2.Index test compared to control3.Conclusions: specific[^3]

PRISMA finally resulted in 48 publications in total, with consensus among all reviewers. The QAI of these studies indicated 13 moderately sensitive and 35 highly sensitive studies.

Data extraction of shortlisted studies[@B7] ^-^ [@B54] (for participant characteristics and study design are as follows ([Table 3](#t3){ref-type="table"}):

Table 3Participant and study characteristics table.Reference no.SaM/FAgeMeIx TcT/gpSiteRnmlFt/o fmcmd/mcreto duNo. / obtm/obBB=c795M/4F10-18yIL-1β, βG1st Mo, 1st PM, CINMMP & MBNRMENMIm FRMEHyraxY81d100, 14, 25, 32, 33, 39, 46, 53, 60, 81 d14dY8145M/9F12.5 ± 1.7yMPOSingle root TNMMB & DBNMNMNMCnLvArch wiN14d4-7d, 0, 2h, 7, 14d0Y9125M/7F16-20y (17.5± 2.4y)ALPMx C & ct C1st MoMs C & D 1st MoYClass I1st q: 150 cN, 2nd q: 50cN, 100cN, 150cNCnRtNiTi spNA3 wk40,1wk, 2wk, 3wk0N102010M/10F15-25yALPMx Cct CMB, MiB,DB, MP, MiP, DPYClass I bimax125gCnRtNiTi spNA3wk60,1h, 24h, 7d, 14d, 21d0N11195M/14F16-28yLDH, AST, TRAP, ALPMx CNMNMY1st PM Ec100/150gCnRtNiTi spNA5wk60, 1, 2, 3, 4, 5wk0Y12205M/15F19± 1.3 yMPOMd INMMB &DBNcrw (severe & minm)NMCnLvArch wi ligNA2wk40, 2h, 7d, 14d0Y13166M/10F13-17y (14 ± 1.67y)TSP1 MMP9/NGALMx Cct CDNM1st PM EcNMCnRtLBNA2wk8-1h,+1h, 4, 8, 24, 72h, 1wk, 2wk-1hN1420 (10Clf/10 non Clf)Clf gp: 7M/3F Non Clf gp: (5M/5F)15-25y (19.75 ± 2.93y)ALP ACP ASTMx I, Mo of same qNMNMNNM150cNCnLvNiTi wiNA30d50, 3, 9, 15, 30d0Y1520 (10 adol, 10 Ad)ado - 3M/7F Ad - 4M/6Fado:14.4 ± 1.43y Ad:28.5 ± 7.83yMMP-9, RANKL, IL-1 IL-1RAMx IMd IDBNClass I minor crwNMCnLvNiTi wiY20wk40, 3, 6, 18, 20wk0Y1640 (4gps)19M/21F12-18yLDH4.1, 4.3 & 4.51.1, 1.3 & 1.5.BuNMClass I Md crwNMCnLvNiTi & thrm wiY42d6-2wk, 0, 1h, 7, 28, 42d-2wkN17169M/7F17.7y(MMPs) -1, -2, -3, -7, -8, -12, -13Mx Cct CMs &DY1st PM Ec150gCnRtNiTi spN21d60, 1, 24h, 7, 14, 21d0N1821NM12-20 yGM-CSF, IFN-?, IL-1β, IL-2, IL-4,IL-5, IL-6, IL-8,IL-10 & TNFα, MMP-9, TIMP-1 & 2, RANKL, OPGMx C2nd MoMB &DPNMMx 1st PM Ec100gCnRtNiTi spN42d4-10wk, 0, 4h, 7d, 42d0N192010M/ 10 F15-25yLDHMx CNMMB, MiB,DB, MP, MiP, DPNMClass I bimax125gCnRtNiTi spN21d50, 1h, 7, 14, 21d0Y20143M/11F12-28y (18.8 ± 4.8 y)MMP-3, MMP-9, MMP-13, MIP-1β, MCP-1, RANTESMx CNMMs&DNMMx 1st PM Ec150gCnRtV- loop & NiTi spN87d7−7d, 0, 1h, 24h, 14, 21, 80d0Y21993 gps; 1st: Non ortho (35M/9F) 2nd;C re (3M/14F) 3rd: Rt (13M/25F)gp 1:22y10m gp 2: 24 y1m gp 3:20y2mCp, cysgp2: Mx Cgp1DNMgp2: 1st PM Ec100-150gImfRtE ChNM1m40, 1d, 1wk, 1m0N22118F/3M13-15y (13.9y)MMP-1, MMP-2L Mx CAg Mx CMB & DBN1st PM Ec150gCnRtNiTi spN8 h50, 1h, 2h, 3h, 4h, 8h0N23105M/5FM - 22.5 ± 2.8y, F - 23.4 ± 3.9y)t-PA& PAI -2M X Cct & Ag CDNM1st PM Ec250gImfRtEchNM168h40, 1, 24, 168h0N24108F12-21yALPMx Cct CMs &DN1st PM Ec100gCnRtNiTi spN21d6-1, 0, 1, 7, 14, 21d-1N2594M/5F14.76±2.08yALPMx 1st PMNMMB,DB,PN1st PM Ec50gImfIntrTMA spY28d50, 1, 24, 168h, 22d, 28d reac-21d0Y26179F/8M11-22 y, 16.1 ±3.8 yLDH1st Mx MoAg & ct 1st Mx MoMs & DNMo dst250gCnRtNiTi spN21d40, 7, 14 & 21d0N2753F/2Mnov/36MMP-1 &8Mx & MdCI/ Mx CMx & Md CINMNMNMCnalnNMN30d310,1-30d,once/d for 1 m0N282111F/10M11.2-22.5y, 17.17 ±3.3 yALP &ASTMxCAg & ct CMs & DN1st PM Ec150gCnRtNiTi spN28d20, 28d0N29105M/5F22.5±3.9yCp BCct & Ag CDNM1st PM Ec250gImfRtE chNM168h40, 1h, 24h, 168h0NRef No.SaM/FAgeMeIx TcT/gpSiteRnmlFt/o fmcmd/mcreto duNo. / obtm/obBB=c301610F/6M11-21y, 15.5±3.5yALPMx 1st Moct &Ag 1st MoMs & DNMMo dst250gCndstNiTi spNM4wk60, 1h, 1, 2, 3, 4wk0N3195M/4F10-18yIL-1β, βGMx 1st Mo, 1st PM & CINMMB &MPNMMx cstNMImFRMEHyraxY74d10BL-0 (B,O1), 14d (c,O2) Al-4d (O3), 11d (O4), 12d (O5), 18d (O6), 19d (O7), 25d (O8), 32d (O9), 39d (10), 60d (O11)0N32123M/9F14.4±0.9 yIL-1β, IL-6, TNF-α, EGF, β2-µGCAg C/ct CDNM1st PM Ec250gImfRtE chN7d40, 1, 24, 168h0N339NM13-17 yTRAP5b, IL-10,TNF-αMx & MdCct CMB, MiB, MP & DB, MiP, DPNM1st PM Ec150gCnRtNiTi spNM28d50, 1h, 24h, 7d, 28d0N341913F/6M16 - 28yALP, AST, TRAPR & L Mx CNMDNMMx 1st PM Ecgp1-100g gp 2-150gCnRtNiTi spNM5wk60, 1wk, 2wk, 3wk, 4wk, 5wk0Y3512NM14-24 yLDHMx CNMMs & DNMClass II C1N & 1.5 NCnRtNiTi spNM5wk60wk, 1wk, 2wk, 3wk, 4wk, 5wk0Y361211F/1M14-24yTRAPMx CBSMs &DY1st PM Ec100/150gCnRtNiTi pushspN5wk60, 1, 2, 3, 4, 5wk0Y37144M/10F15-27yALPMx CNMMs &DNMcrw (4-8mm)NMCnlv, alnNiTi wiN3wk40, 1, 2, 3wk0Y38108F/2M15-27yALPMx CNMMs &DNM1st PM Ec150gCnRtNiTi pushspN12wk50, 1, 4, 8, 12wk0Y3913NM14.4±3.7y, 23.3±4yASTMx Cct CMs &DNM1st PM Ec100gCnRtNiTi pushspN12wk50, 1, 4, 8, 12wk0N4013 (6ado, 7Ad)NM14.4±3.7y, 23.3±4yASTMx PMAg PMMs &DNM1st PM Ec50-75gCnLvNiTi wiY28d50, 7, 14, 21, 28d0N412212F/10M13-22yASTMx CNMMs & DYNMNMCnLvNiTi wiNM6m50, 1wk, 1m, 3, 6m0Y42127F/5M14±2yACP, ALPMx CAg C, ct CMs & DY1st PM Ec250gCnRtNiTi open coil spNM28d30, 14, 28d0N43105F/5M15-20yALPMxC, Mx 2nd PMNMD of C & Ms of 2nd PMNM1st PM Ec150gImFRtE chNM28d60, 1, 7, 14, 21, 28d0Y442315F/8M9±1.4yALPMx rt & lt 1st MAg ist MMB, MiB, DB, MP, MiP, DPNMMx constr16N/turnImFMx ExpHyr2/d6m30, 3, 6moN45107F/3M14 - 27 yALPRt Mx CLt Mx CMs, DNM1st PM Ec250gCnRtNiTi spNM4wk60, 1h, 7, 14, 21, 28d0N4675F/ 2M14 - 27 yACPRt Mx CLt Mx CMs, DNM1st PM EcNMCnRtNiTi spNM4wk60, 1h, 7, 14, 21, 28d0N47209F/11M12- 25 yLDHMxCct CMB, MiB, DB, MP, MiP, DPNM1st PM Ec125gCnRtNiTi spNM21d60, 1h, 1, 7, 14, 21d0N481810F/8Mnov/22ASTMax 1st Moct & Ag 1st MoMs & DNMo dst250gCnRtNiTi spN4wk60, 1h, 1, 2, 3, 4wk0N49206F/4M20.6 ± 3.2yALPMx C, Md CBSDY1st PM Ec200 cNImf vs CnRtHycon, TieBScrew 2/wk28d60, 1hr, 7, 14, 21, 28d0Y505528F/ 27M15.1 (1.7)Adiponectin, Leptin, Resistin, MPO, CRP, MMP 8,9, TIMP1, MMP8/TIMP1, MMP9/TIMP1,RANKLMand 6 anterior teethNormal weight childrenDNMNon EcNMCnAlnNiTi wiNMCompletion of Aln40, 1h, 1wk, completion of Aln0N512214F/8M11-21yALPMax 1st - M rt &LtMand 1st - M rt & LtNMMBExp400gImfMx ExpHyr1/3m1y40, 2wk, 4wk, 1y0N526041F/19M18 ± 1.5MPOMand CIBSNMNM4-6mm mand I crowNMCnAlnMSSS, HANT, SE wiN14d40, 2h, 7, 14d0Y5345NM6.25, 5.6, 6.10MPOMand IBSNMY4-6mm mand I crowNMCnAlnMSNiTi, HANT, SE wiN14d40, 2h, 7, 14d0Y5430NM9-15yASTRt Mx PMLt Mx PMNMNMNMNMCnAlnNiTi wiN4wk60, 1h, 1, 2, 3, 4wk0N[^4]

» Sample size: Sample size was categorized in three groups, ≤15 (n=22), 15-20 (n=15), ≥21 (n=10) and one study each having sample of five subjects[@B27] and 99 subjects.[@B21]» Sex predilection: Forty- one studies mentioned sex distribution in the sample, two of which had female subjects only,[@B24] ^,^ [@B36] and five had equal numbers of male and female subjects.[@B10] ^,^ [@B19] ^,^ [@B23] ^,^ [@B29] ^,^ [@B43]» Age predilection: Studies used age as either range or mean with standard deviation in all studies; one study considered two separate age groups of adolescents and adults.[@B15]» Number of studies reporting enzymes: Alkaline phosphatase was evaluated in maximum number of studies (n=17), closely followed by AST in 10, matrix metalloproteinases (MMPs) in eight, LDH in six, MPO in five and TRAP in four and acid phosphatase (ACP) in three studies. Two studies studied βG, cathepsin (Cp) and tissue inhibitor of MMPs (TIMPs) each. Single studies evaluated cystatin (Cys) and thrombospondin1 (TSP1). Additionally, granulocyte-macrophage colony-stimulating factor (GMCSF), epidermal growth factor (EGF), macrophage inflammatory protein-1β (MIP-1 β), methyl-accepting chemotaxis protein-1 (MCP-1), chemokine RANTES (Regulated on activation normal T cells expressed and secreted) were evaluated as secondary outcomes.» Study duration: The duration of studies ranged from 8 hr to 24 weeks (wk) to the maximum of one year (y). One study each was done for 8hr, 1wk, 5month (m) and 1y duration, two studies for 6m, three for 2m, five each for 2wk and 3m, eight for 3wk, 15 for approximately 1m. One study did not specify duration - only completion of alignment.» Observation intervals for GCF collection: Studies had GCF collection at repeated observation time points (OTP) ranging from 2 times[@B28] to 31 times (each day of the month).^27^ Six OTPs were taken in 16 studies, closely followed by 4 OTPs in 15 studies, 9 OTPs in nine studies, 3 and 10 OTPs in two studies each, 2, 7, 8 and 31 OTPs in single study each.» Site for GCF collection: Forty one studies specified mesial or distal or buccal site for GCF collection while seven studies mentioned the tooth but not the site for sample retrieval. The technique by Lamster et al.^55^ utilizing six sites was used in four studies.[@B10] ^,^ [@B19] ^,^ [@B33] ^,^ [@B44] ^,^ [@B47]» Mechanics of force: Studies used continuous force both for tooth retraction (26 studies) and leveling of arches (13 studies). Retraction involved 19 studies using NiTi coil spring, two using steel ligature lacebacks, three using NiTi push coil spring, and one study each for V loop and NiTi open coil spring. Besides, nine studies used intermittent orthodontic/orthopaedic forces, employing elastomeric chain for retraction in five, Hyrax for expansion in three, and TMA spring for intrusion in one study.» The level of force: Only 33 studies mentioned force levels for OTM. The level of forces ranged from 50g, 50-75g, 100-150g, 16N/turn, 1-1.5N, 200cN, 400g in one study each, 125g in three, 100g in six, 250g in eight and 150g in seven studies. Few studies had different treatment groups employing variable magnitudes of force.[@B9] ^,^ [@B11] ^,^ [@B34] ^,^ [@B35] ^,^ [@B36]

Oral hygiene regimen and gingival health assessment (Table 4)
-------------------------------------------------------------

Table 4Oral hygiene regimen.Ref No.Oral px (Pre t/t)Oral px (Every ob po)Oral hy instr/motivMwfq/o mw/dasm for gv & pd in (pre t/t )At every ob po7YNMYCx glu2YY8YNMNMNMNMYNM9NMNMY0.15% Benz HCL/d1 /dNMNM10YNMY0.5 oz of 0.2% cx glu2/dNMNM11YNMNMNMNMYNM12NMNMNMNMNMNMNM13YYYNMNMNMNM14YNMYNMNMYY15YNMNMNMNMYNM16YYYNMNMYY17YYY0.5 oz of 0.2% cx glu2/dYY18NMNMNMNMNMYY19YYY0.5 oz of 0.2% cx gluYYY20YYY0.12% cx glu2 /d for 4 wkNMNM21NMNMYNMNMYNM22NMNMYNMNMNMNM23YYNMNMNMYY24YYYcx glu2/dYNM25NMNMNMBenz HCLNMNMNM26YNMYNMNMYY27NMNMNMNMNMYNM28YNMYNMNMYY29NMNMNMNMNMYNM30NMNMYNMNMYY31YNMYcx gluNMYY32NMNMNMNMNMYY33YNMYNMNMYY34NMNMYNMNMNMNM35YNMYNMNMNMNM36YNMNMNMNMNMNM37YYYNNYY38YYYNNYY39YYYNNYY40YYYNNYT41YYYNNYY42NMNMYcx glu2 /dYY43YNMYN(against it)NYNM44YYY0.012% cx glu2/dYY45YYYCx gluNMYY46YYYNMNMYY47YNMYNMNMYNM48YNMYNMNMYY49NMNMNMNMNMNMNM50NMNMNMNMNMYY51YYNMNMNMYNM52YNMYNMNMYNM53YNMYNMNMYNM54YNMNMNMNMYNM[^5]

GCF characteristics (Table 5)
-----------------------------

Table 5GCF characteristics.Ref No.Timetphmmt/o clins (in mm)du/o mmrep mmi/o mmmt/o mmtp of stmt/o alpr cc7NM30%21°CPPNM30sNMNMPT6000NMELISApg /30-s8NMNMNMPPNM30s4NMNM-70°CSPPMNs/µl9NMNMNMPP1mm1min31minNMNMSPIU/1 µl10NMNMNMPPNM1minNMNMPT 8000-70°CSPIU/L11NMNMNMPP1-2mm1min3NMNM-20°CELISALDH, AST-mIU/ml, TRAP, ALP-ng/ml12NMNMNMPPNM30s4NMNM-70°CSPU/100 ml13NMNMNMPPNM30s31minPT 8000-20°CELISAng/ml14NMNMNMµPNM5minNMNMNM-70°CSPU/µl15NMNMNMPPNM1minNMNMNM-80°CQAKpg/ml16NMNMNMPP1mm30sNMNMNM-30°CSPµg / ml17NMNMNMPPNM30sNMNMNM-70°CIApg/site18NMNMNMPPNM30sNMNMPT 8000NMLMATpg/ml19NMNMNMPPNM1min5NMNMNMSPµmolU/L20NMNMNMPP1mmNMNMNMPT 8000−80°Cmb-IApg/site21NMNMNMPPNM30sNMNMPT8000-80°CFlrCp; µU/ µl, Cys; ng/µl229am20°C40%PPNM30sNMNMNM-70°CWBNM23NMNMNMPP1mm1min21minPT8000-30°CELISAµg/µl24NMNMNMµPNMNMNMNMNM-70°CNMNM25NMNMNMPPNM1min25sNM-80°CELISApmol/mg26NMNMNMPP1mm30sNMNMNM-80°CSPmU27NMNMNMPPNM3minNMNMNM-20°CWBµg/l28NMNMNMPP1mm10sNMNMNMNMSPmU/sample29NMNMNMPP1mm1min130sNM-30°CWBpU/µl30NMNMNMPP1mmNMNM30sNMNMSPmU/sample31NM21°C30%PPNMNMNM30sPT6000-70°CELISAU/30-s GCF sample32NMNMNMPP1mm1min130sPT-30°CELISApg/µg33NMNMNMPPNMNMNM30sPT8000-20°CELISApg/µL34NMNMNMPP1-2mm1min21minNMNMSPµmol/ min35NMNMNMPP1mmNMNM1minNMNMSPU/mg36NMNMNMPP1mm1min31minNMNMSPU/mg37NMNMNMend PP1mm30s390sNM-40°CSPµmol/min38NMNMNMend PP1mm30s390sNM-40°CSPµmol/min39NMNMNMend PP1mm30s390sNM-40°CSPµmol/min40NMNMNMend PP1mm30s31minNM4°CSPµmol/min41NMNMNMµP2mmNMNMNMNM-70°CSPU/mg42NMNMNMPP1mm30sNMNMNM-20°CSPNM43YNMNMFPNM1minNM5sNM-80°CPNPP kinNM44NMNMNMFP1mm30sNMNMNM-80°CSPmU/sample45NMNMNMµPNMNMNMNMNMNMSPU/L46NMNMNMµPNMNMNMNMNMNMSPU/L47NMNMNMµPNMNMNMNMNM-80°CSPµmol units/L)48NMNMNMpp1mm30sNMNMNMNMSPmU/sample49NMNMNMµPNMNMNM30sNMNMSPIU/L50YNMNMPP1mm30sNMNMPT8000-80°CSPpg/mL51NMNMNMend PP1mm30sNMNMNM-30°CSPmU/sample52NMNMNMPPNM30s430sNM-70°CSPunits/100 µL53NMNMNMPPNM30s230sNM-70°CSPunits/100 µL.54NMNMNMpp1mm1minNMNMNMNMSPmU/s[^6]

» GCF collection: GCF was collected by Periopaper (OraFlow, Plainview, New York, NY, USA) in 32 studies, micropipette in seven, filter paper in two, paper point in two and endodontic paper strip in five studies. Time of sample collection, room temperature and humidity conditions were specified in three studies each.

» GCF handling: Depth of Periopaper insertion was 1mm in 21 studies, 1-2mm in two, and 2mm in one study. Duration of GCF collection was 30 seconds (s) in 21 studies, 60s in 13 studies and 10s, 3 minutes (min) and 5 min in one study each. GCF measurements were repeatedly taken in 18 studies with specified number of intervals, interval of repeat measurements were 30s (n=8), 60s (n=7), 90s (n=3) and 5s (n=2). Storage of samples was done at -20^o^C (n=5), -30^o^C (N=4), -40^o^C (n=3), -70^o^C (n=11) and -80^o^C (n=9). Retrieval of GCF from Periopaper was done by Periotron (OraFlow, PlainView, New York, NY, USA) in 11 studies, but not mentioned in 38 studies. Enzymes levels were estimated by ELISA (n=8), spectrophotometry (n=30), immunoassay (n=2), Luminexmultianalyte technology (n=1), Quantibody Array kit (n=1), western blotting (n=3), fluorometry (n=1) and para-nitrophenol phosphate kinetic (n=1), but omitted in one study. Protein concentration in GCF was measured in variable units in 38 out of 42 studies.

DISCUSSION
==========

The findings of the current review are presented in [Table 6](#t6){ref-type="table"}. It depicts various enzymes released in GCF in a time-dependent manner and also establishes correlations (if any) with levels or type of force applied. In this review, we have tried to establish associations of enzyme levels to magnitude or type of force in each phase of OTM, given by Burstone[@B56] in his classic model or four phase time/displacement modification model.[@B57] ^,^ [@B58]

Table 6Differential expression of enzymes in GCF.Ref No.sts al apcfDrop outsUp / down rgPksd occrsts sn rd71-tailed paired Student tYNMβG: incM-010 PM-07 CI-08IL-1β sign inc for Mo- O5 to O10 for PM-O6 to 010 For CI-04, 06, 07, 09, 010 & dec at O2 for Mo, PM, CIstronger F cause higher levels of IL-1β & βGβG inc for Mo- 07 to 010 PM-07, 08, 010 CI-06, 07, 010 & dec at O2 for Mo, PM, CI8ANOVA, paired t testYNaMInc at 2h, bas in 7d2hInc MPO in saliva at 2h, B in 7d+ve cr of lvl in GCF & salivaInc at 2h9(ANOVA) Kolmogorov-Smirnov test, Paired-samples testYNInc2wkNMNMIn cns F: Lvl pk at 2wk In gradually inc F: Lvl pk at 3wk10Kolmogorov and Smirnov (ANOVA) & Tukey's post-hoc testYNInc14dGCF vol inc from 0 - 21d Sn inc at 14dExp si; lvl inc on 14d cr with pk in GCF volExp si; pk at 14d11Paired t test Pearson's crYNLDH inc at 2, 3& 4 wk(100 g) & 1, 2 & 3wk (150 g). AST inc at 4 & 5wk (100 g) & 3 & 4wk (150 g). TRAP inc at 5wk (100 g)AST: 1wk TRAP: 2wk ALP: 5wkIn saliva:AST inc at 5wk, TRAP at 2wk, ALP at 1 to 5wkWeak cr b/w enz quantity & activityLDH inc at 2, 3 & 4 wk (100 g) & 1, 2 & 3wk (150 g). AST inc at 4 & 5wk (100 g) & 3 & 4wk (150 g) TRAP inc at 5wk (100 g)12Friedman test for intergp & intragp, Wilcoxon test for related samples, Kruskal-Wallis test for independent samples in both gpsYNinc2hminm & severe crw: inc from 0 at 2h, 7d, 14d in salivaNo cr of crw with change in MPOAt 2h, 7d sn inc from B & 14d13Intra gp: Friedman's test, Wilcoxon test Inter gp: Mann-Whitney U test, Pearson's testYNincMMP9: 8h MMP9/NGAL: 72hTSP1: inc from B at 8h to 72h, dec at 1wkStrong & sn cr b/w MMP9/NGAL & TSP1 in IxTMMP9: inc from B at 4h, 8h, 1wk, 2wk. MMP9/NGAL: inc from B at 8h,24h, 72h14Intergp: Mann Whitney U test. Intra gp: Students unpaired t-testYNIncACP: 3d ALP, AST: 15dNMNMInter gp; ACP: pk at 3d ALP, AST: pk at 15d Intra gp: ACP, ALP, AST higher in Mx I than Mo15SAS version 9.2 proc mixed subroutineYNNo sts sn changeNMExp si: in Ad, IL-1/1L-1RA dec in 3wk aftr 1st wi lig ado, RANKL/OPG pk at 6wk aftr 1st rect wi ligNMb/w Exp & cT; no sts sn change B/w Ad & adol: no sts sn diff16MedCalc software Intergp: Student's t-test, ANOVA.YNSL+ NiTi wi: inc SL+ thrm wi: decNo sts sn changeVisual pl scr dec sts snNMNo sts sn change b/w Exp & cT or within each gp17Luminex analysisYNMMP1,3:inc, pk at 24h MMP8: pk at 14d24hNMNMNo sts sg diff b/w comp & tn, MMP1, 3: inc, pk at 24h MMP8: pk at 14d18Paired non-parametric Kruskall-Wallis. Spearman Rank Sum analYNMIncExp-TIMP, MMP-9:4h cmp: TIMP-1, MMP-9:4h, TIMP-2: 7d+ve cr of GCF vol & PI at 0 at tn, cmp +ve cr of TNF-α, IL-1β, IL-8, GM-CSF to speed of OTM at 4h in Exp cr of IL-1β, IL-8, TNF-α inc to if at 0 at cmp+ve cr of MMP-9 & TIMP to speed of OTM at 4h in ExpTIMP1 & 2, MMP-9 inc at 4h in Exp19GraphPad®Instat, ANOVA, FriedmanYNMInc14d, 21dNMNMInc at 7, 14, 21d20Friedman, Mann-WhitneyYNMInc1hGCF vol higher in cmp than tn at 21dNMMMPs inc at 1h, dec at 24h21ANOVANMCp: dec Cys:inc1dGCF vol inc in 1d, dec at 1m-ve cr in Cp & Cys LvlCp;dec at 1d, inc to B in 1m Cys;inc in 1d, dec to B in 122ANOVAYNMIncMMP1-1h MMP2-1h,8hNMNMInc in MMP1 (tn) -1h-3h, (cmp) -1h Inc in MMP2 (tn) - 1h, (comp)-8h23Mann-Whitney U-testsNNMInc at 24h at Ix t \>cT24hGCF vol no sn diff at 24hNMInc at 24h24ANOVA &LSDYNMInc14dNMNMInc in ALP -7, 14 at Ms & D25Friedman testYNMDecI dDpd, osteocalcin decNMDec from 0 to 28 d, inc on 7d26Friedman and Bonferroni-corrected, Wilcoxon paired signed rank testsYNMInc14dNMNMct gp greater than Ag gp on 14 d & 21d27NMYNMLvl of MMP-8 inc in Ix t\>cNMNMNMLvl of MMP-8 inc 12 times in Ix t\>c28Friedman & Bonferroni-corrected, Wilcoxon paired signed rank testsYNMInc28dAa colonization inc sn on 28d in ExpT & ct gpNMInc at 28d in Ix T as compd to Ct T & Ag T29Friedman & Bonferroni-corrected, Wilcoxon paired signed rank testsYNMInctn:7d cmp:7&14dNMNMAST: inc in Ix T & ct T as compd to Ag T, inc in IxT as compd to ctT on tn si on 14d & on cmp on 7d & 14d, inc in IxT on cmp than tn on 7d30Mann Whitney U-testYNInc24hNMCpB higher at 24h at IxT31Bonferroni-corrected, 1-way repeated measures ANOVA, paired Student t testYNMInc14dNMNMSign inc on both M & D at 1,2,3,4 wks32One-tailed paired Student t testYNIncβG -25d IL-1β-sn inc in IL-1β level at 4d &19d to 60d ALNMinc in βG at 25d to 60d AL33Student's t testYNIL-1β, IL-6, TNF-α, EGF, β2-µGinc24hIntra-grp in Exp: IL-1β inc at 24h \> BS,IL-6 inc at 24h \> BS or 168h,TNF-α inc at 24h \> BS or 168h, EGF inc at 24h\>BS Intergrp btw cont & Exp: IL-1β inc in Exp\>cont at 24h, Mean IL-6 in Exp \>ant cont, TNF-αin Exp at 24h\> ant cont, EGF in Exp at 24hr\> ant contNMRef No.sts al apcfDrop outsUp / down rgPksd occrsts sn rd34ANOVAYNMInc7dTNF-α in D & Ms sites of TT sn higher than both sites of c, also \>.B, inc sn at 1 h & 24h. IL-10 dec during Exp period at c & TTNMTRAP5b Level in D & Ms sites of TT were sn higher than that at both sites of cT compd with B values, inc was sn at 1 h & 24h.35Shapiro-Wilk testYNMinc100g gp-TRAP-3wk 150g gp-ALP & TRAP -5wkNMNMIn 100 g gp, TRAP sn inc in 3-5 wk compd to TRAPB. ALP & AST slightly inc. In 150 g gp, ALP & TRAP slightly inc compd with their B. AST sn inc in 5 wk.36Student's paired t testYNMIncM:4wk D:1.5N-2wkNMNMLDH at Ms site in 1.0 N &1.5 N gp, inc sn on 4th wk. At D site, LDH with 1.5 N was higher than 1.0 N throughout 5 wk of TM. LDH with 1.5 NF inc at both Ms (wk 2) & D site (wk 3) with sn diff to 1.0 N F37Kruskal Walis test.YNMTRAP inc in 150g F: Ms site peak 3wk, D site Pk 4wk den dec 100g F: Ms site 2wk Pk den dec, D site 5wk 4wk: Lvl in 150g\> 100g F (D site) 5wk: Lvl in 100g\>150g F (Dsite)150g: D site -4wk, Ms site-3wk 100g:D site-5wk. Ms site-2wkRate of OTM at 150g\>100g150g F at 3 & 4wk\>100g f, +ve cr of Lvl of TRAP & rate of OTM150g gp, Ms si: inc at 3wk\>BS At D si: inc at 4k\>BS TRAP at 150 gm\>100gm F at 4wk (D site)38Paired sample t-testYNMinc, pk at 2wk, at D \>Ms- 1wkMs, D Si: 2wkNMNMInc at 1wk, 2wk from Bas39Paired sample t-testYNMDec: 1wk,4wk on Ms, D si4wkNM-ve cr of amt of OTM & Lvl of ALPDec at 4wk40Wilcoxon signed rank testYNMInc: at 1wk,4wk, stabilised4wkNMNMInc at 1wk, 4wk, At D si\>Ms si41Wilcoxon signed rank testYNMInc at 1wk, dec in next 3wk1wkNNMPk at 1wk at Ix T\>cT42unpaired and paired t-testYNMInc at archwi \>self lig site, inc at 1wk1wkBac count in archwi\>self lig+ve cr in self lig & AST LvlInc at archwi \>self lig43ANOVA, paired t-test using SPSSYNMALP, ACP inc at 14d, 28d, ALP at Ms\>D, ACP inc in Ms &DALP, ACP : 14dNMNMALP, ACP inc, ALP inc more on M si44ANOVA, Student\'s t-testYNMALP dec, D of C \> Ms of 2nd PM on 1, 7, 14, 21, 28dDecNMNMDec at D of C \> Ms of 2nd PM on 1, 7, 14, 21, 28d45Friedman test followed by a Bonferroni-corrected Wilcoxon paired signed rank testYYALP inc in 3m, 6mIncPD with ALP actv+ve corr of ALP lvl with time at tn siALP at 3m, 6m \> cT46ANOVA,Tukey's HSD Post-Hoc test, Mann-Whitney U-testYNMALP inc 14d, 28d28dNMNMALP at Ms si of TT\>CT at 14d, 28d At Ms si\>Dsi at 14d, 28d47ANOVA, Independent Samples t-test, Mann- Whitney U-testYNMACP inc both Ms & D si D si\>M si at 7d, 21d21dNMNMD si\>M si at 7d, 21d TT\>cT at 7d, 21 d at Dsi48ANOVA,Tukey HSDYNMLDH inc at TT\>cT 7d, 14d,21d28dNMNMLDH inc frm 7d-14d at TT, TT\>cT at 7, 14, 21d49Friedman & Bonferroni-corrected Wilcoxon paired signed rank testsYNAST inc from BS in T/t gp from BS to 2wk followed by dec Inc in CC gp from BS to 1wk followed by dec AST level in comp \>tn on 1wk14dGCF flow in T/t=CC\>AC gp+ve correl of mechanical stress to AST levels, T/t\>CCsn inc in T/t &CC vs AC gp: 1, 2, 3, 4w sn inc in T/t vs CC gp: 1, 2wk AST level in comp \>tn on 1wk50One-way ANOVA was used for multiple group and Student t test for group-wise comparisonsYNinc in ALP b/w 21d & 28d :of 200% in active TB gp, of 260% in Rt screw gpTB: 21d Rt screw:28dSpace closure rate, root resorption, Rt, anchorage loss with Hycon screw were assessed+ve correl of ALP in Hycon screw gp with actvn of screwSign diff in ALP on 21d & 28d b/w TB & Rt screw gp51independent t tests, \_2 tests, or Mann-Whitney, intraexaminer reliability - concordance correlation coefficient (CCC) & Bland-Altman methodNYMMP8,9, MMP8/TIMP1, MMP9/TIMP1, resistin at BS\>1h\>1wk\>compl of Aln CRP, MPO, TIMP, RANKL inc from BS to compl of Aln Adiponectin BS\<1h\<1wk\>compl of Aln Leptin dec from BS to compl of AlnNMresistin at BS\>1h\>1wk\>compl of Aln CRP, RANKL inc from BS to compl of Aln Adiponectin BS\<1h\<1wk\>compl of Aln Leptin dec from BS to compl of AlnMediators correl with Aln rate- MPO, RANKL, Leptin, ResistinMPO at BS\<1h\<1d\<compl of Aln52Fisher's PLSD followed by post hoc, Bonferroni- DunnYNALP on cmp site: 0\>2wk\>4wk\<1y tn site: 0\<2wk\<4wk\<1ytn site: 1y cmp site: before actvnNM+ve correl of intermolar distance with ALP level in tn sitetn site:0 (before actvn) \< 4wk, 0\<1y cmp site: 0\>4wk, 0\<1y, 2wk\>4wk53paired & unpaired 't' test and ANOVA.YNMPO inc from BS to 2h in HANT, SE, MSSS gp2hNMMPO in HANT\>SE\>MSSSsn diff in MPO b/w SE & MSSS :2h, 2wk, b/w HANT & MSSS:2h, b/w SE & MSSS:1wk54Chi-square Student's t-test, and one-way analysis of varianceYNMPO inc from BS to 2h in HANT, SE, MSNiTi gp, HANT\>SE & MS NiTi:2h2hNMNMsn diff b/w SE & MSNiTi: 2h, 1, 2wk, b/w HANT & MSNiTi:2h55Independent & paired sample t- testYNAST inc from BS to 1wk, then dec in Exp gp1wkNMNMLevels greater in Exp than Cn gp at 1, 2, 3, 4wk[^7]

An initial upregulation in enzymes for bone resorption and matrix degradation like TRAP, ACP or MMPs and an immediate decrease in bone formative ALP corresponded with Burstone's initial phases of OTM. Different MMPs responsible for extracellular matrix (ECM) breakdown are increased at variable times in OTM,[@B13] ^,^ [@B15] ^,^ [@B17] ^,^ [@B18] ^,^ [@B20] ^,^ [@B22] ^,^ [@B27] ^,^ [@B50] as early as 1hr or till completion of alignment.[@B50] MMP-9 increased in 4hr, peaked at 8hr using stainless steel ligatures for canine retraction in one study, while MMP9/NGAL ratio peaked in 72hr in another study.[@B13]

MMPs also varied with different magnitudes of force as MMP-9 peaked in 4hr in a study using 100g force for canine retraction,[@B18] compared to another study using 150g force in which MMP3, 9 and 13 peaked in 24hr.^20^ The difference in peaks of various MMPs can be explained on the basis of difference in their roles in bone turnover and remodeling with orthodontic forces.[@B59] MMP-9 is responsible for cleavage of denatured collagen, i.e gelatin;[@B60] MMP-13 dissolves native fibrillar collagen; MMP-1 is an interstitial collagenase hydrolyzing mainly type III collagen,[@B61] and MMP-3 is responsible for activation of MMPs 8 and 9.[@B62] Hence peaks of MMP8 and MMP9/NGAL ratio at 14d[@B17] and 72hr,^13^ respectively, occur subsequent to peak of MMP-3 in 1hr/24hr.[@B17] ^,^ [@B20] In vitro studies also support rise in MMPs in orthodontic forces, specifically MMP-1,2 mRNA and protein production in human gingival and pdl fibroblasts[@B63] ^,^ [@B64] and MMP-1,2, 9 in gingival tissue of dogs.[@B60]

On the other hand, no significant change in MMP levels were seen in control teeth where no orthodontic force was applied.^17,22^ This clearly supports MMPs as key mediators of remodeling in OTM.

MMPs are also shown to vary with site (tension and compression) in a time-dependent manner, as supported by in vitro models on pdl fibroblasts.^65,66^ Current review showed an increase in MMP1,2 in 1-3hr on tension site (TS) of maxillary canine after activation of NiTi spring while in compression (CS), MMP1 increased at 1hr and MMP2 later, at 8hr.[@B22] MMP-9 also increased from 4hr to 7d on compression site in another study.[@B13] This upsurge in levels indicate initial collagen turnover and disintegration of ECM on both tension and compression sites in initial phases of OTM.

Contrary to the MMPs, CS showed a significant increase in GCF levels of MMP inhibitors, TIMP-1 at 4hr and TIMP-2 after 7d during retraction of canines, coinciding with lag phase where tooth movement slows down.[@B18] ^,^ [@B50] At TS, a significant increase in TIMP1 and 2 levels was seen at 4hr, 7d and 42d. This finding is in agreement with the results of a study by Bildt et al[@B67] where a continuous force with NiTi spring of 150cN was applied for retraction and an increase in MMP1 and TIMP1 was seen on pooled samples from resorption (corresponding to compression) and apposition side (tension) but no trace of TIMP2 was found. The mechanism of action of TIMP-1 stimulates release of MMP1,[@B68] an interstitial collagenase, associated with normal tissue remodeling or stretch of pdl fibers, hydrolysing mainly type III collagen.[@B64] Also, TIMP-1 increases in smaller amounts on the site of compression, while retraction due to stimulation of bone resorption but in higher amounts on tension, it decreases bone resorption.[@B67] A study by Garlet et al.[@B69] provided evidence of greater expression of TIMP-1 mRNA on TS and MMP-1 mRNA on CS and TS of experimental teeth compared with the control.

Besides MMPs, histological studies on rats provide evidence of other enzymes for bone resorption predominant in CS in early phases of OTM followed by bone deposition in TS.^70,71^ In accordance, the current review also shows resorptive enzyme -ACP in initial 3-5d of tooth movement.^14^ Few studies on retraction with continuous forces document an initial rise in ACP both on TS and CS with a peak in 14d^42^ and 21d.[@B46] Initial resorption is followed by a late phase of bone deposition (7-14d) marked by an increase in bone formative ALP levels,^37,45^ seen both in TS and CS of alveolar wall. Increase in ALP occurs by increasing the local concentration of phosphate ions after hydrolysis of phosphomonoester bonds, thus bone mineralisation. Highest serum ALP activity in humans has been correlated with greatest osteoblastic activity during growth spurts.[@B72] ^,^ [@B73] The current review has 17 studies evaluating ALP in association with type, site and magnitude of force. ALP levels increased at TS in continuous retraction forces by NiTi spring as well as in gradually increasing force from 50 cN to 150cN at 2wk, showing a predisposition towards bone deposition.[@B9] A study in rats supported osteoid deposition in the lacunae on TS in 80-120d.^74^ The current review shows peak in ALP levels at 2wk on continuous force application of 150cN, 100g or 150g force[@B9] ^,^ [@B10] ^,^ [@B14] ^,^ [@B24] ^,^ [@B28] ^,^ [@B45], with greater levels on TS compared to CS. This is followed by fall in ALP levels corresponding to hyalinised tissue removal and initiation of post lag phase.[@B9] ^,^ [@B24] Magnitude of force was another determinant of variation in ALP. Decrease in ALP levels seen at 1hr, 1d after intrusion by TMA spring is believed to be caused by heavy forces leading to a hyalinised zone.^25^ Conversely, distalisation of molars with heavy cF of 250g[@B31] showing high ALP levels at both TS and CS and ALP levels greater in 150g than 100g force,[@B34] were attributed to extensive osteoblast recruitment on application of heavy forces.^9^ One study showing decreased ALP levels on both TS and CS of canine retraction with push coil spring was probably due to combination of bodily and tipping movement, which precludes pure compression and tension areas.[@B38] ALP also varied with type of force: one study compared levels in Hycon^®^ screw with active tie-backs for retraction. A significant difference was seen at 3 and 4 wk of retraction with levels in Hycon screw group 260% higher after one half turn twice weekly activation, compared with 200% increase in active tie-back group.[@B49] This may be ascribed to elastomeric force decay to 30-40% of original force in 3 weeks. Another study on maxillary expansion by hyrax followed by retention noticed fall in ALP levels on CS and TS till four weeks of activation, followed by peak at 1yr on TS, thus indicating bone apposition during retention period.[@B51]

Contrary to ALP, TRAP or ACP facilitates dissolution of bone minerals by forming a highly acidic extracellular environment and are potent osteoclast biomarkers expressed in areas of compression.[@B74] The present review supports rise in TRAP levels at CS more than TS to reach peak at 1wk,[@B33] 2wk^11^ and 4-5wk.[@B34] ^,^ [@B36] This is supported by histochemical study by Casa et al,[@B75] suggestive of appearance of mononuclear TRAP positive cells on application of forces at 2wk and multinucleated TRAP positive cells at 3 and 4wk. Even ACP activity was maximum at 3d, followed by its reversal, explained by natal release of enzymes from surface of osteoclasts.[@B14] A secondary outcome of faster rate of OTM with minimal lateral and apical root resorption was noticed with higher levels of TRAP in 150g, compared with 100g force.[@B34] ^,^ [@B36]

The consummation of bone resorption occurs by resolution of organic matrix mediated by lysosomal cysteine protease cathepsin B that is increased 1d after application of 100-150g or 250g retraction force by E chain,[@B21] ^,^ [@B30] while levels of inhibitor cystatin decreases in 1d.[@B21] In association, plasminogen activator (t-PA) and its inhibitor (PAI) responsible for extravascular fibrinolysis, reach peak at 24hr only to fall later at 7d.[@B23]

AST is another cytoplasmic enzyme released in extracellular environment after cell membrane lysis following necrosis[@B76] and has been evaluated in 10 studies in the current SR. Peak levels of AST were seen at 1wk,[@B11] ^,^ [@B40] ^,^ [@B41] ^,^ [@B54] 2wk,[@B14] ^,^ [@B48] and 4wk.[@B28] ^,^ [@B39] This may be explained on the basis of increase in AST activity for 14d due to hyalinization of pdl in compression zone, decreased later upon resolution of hyalinized area by macrophages.[@B14] The formation of hyalinised zone and cellular necrosis may cause higher levels on CS than TS in retraction cases[@B39] ^,^ [@B48] and also in 150g force, compared to 100g.[@B11] ^,^ [@B34] But, such sporadic evidence could not be definitive for site predilection. Rather this enzyme has been associated more with destruction of gingival tissues in experimental and chronic periodontitis[@B77] and subgingival colonization with arch wire ligation[@B41] than orthodontic force application.

The current review has also monitored LDH, an enzyme released from cytoplasm to extracellular space after cell death in gingivitis or periodontitis[@B78] as well as in orthodontic treatment.[@B16] ^,^ [@B26] Variation in LDH levels were recorded with type, magnitude and direction of application of force. Continuous force of 125g with NiTi spring showed increase in levels at 7d to peak at 14d,[@B26] 21d[@B19] and 28d,[@B48] but remained higher in CS than TS at 1.5 N,[@B35] thus favouring its release after cell death. Timing of increase varied with force level, with an early increase seen at 2wk in heavy force of 250g applied for molar distalisation.[@B26] compared with rise in 3wk in 125g force.[@B19] ^,^ [@B47] However no significant difference in LDH levels could be correlated to high friction between self-ligating brackets and thermoelastic or superelastic Nitinol wires, as the forces produced by frictional resistance are insufficient for LDH release.[@B16] One study supporting greater LDH levels in teeth undergoing retraction compared with controls was excluded from this review because of its cross-sectional study design.^79^ It supported LDH as a sensitive marker of the pdl metabolism changes during OTM.

Other inflammatory mediators like MPO and βG were also evaluated in this review. MPO released from PMNLs (polymorphonuclear leukocytes) is a sensitive marker for inflammation and pain associated to OTM and showed an early increase at 2hr.^8,12,50,52,53^ In cases of alignment, the levels of MPO increase from baseline to 1hr to 1d till completion of alignment, correlating it with inflammation caused by NiTi wire alignment.^50^ Studies on MPO also supported superelastic NiTi wires as best alignment wires, giving low continuous force and rapid tooth movement, showing higher MPO levels at 2hr, compared with heat-activated NiTi or multistranded NiTi or stainless steel wires.[@B52] ^,^ [@B53] Studies also mentioned increase in lysosomal enzyme, βG released from PMNLs after 14d of heavy interrupted force for mid-palatal hyrax expansion in adolescents.[@B7] ^,^ [@B31] However, the levels remained high till 28d in retention, probably due to elastic recoil of stretched supracrestal gingival fibers.[@B7] ^,^ [@B31]

The risk of bias assessment in QAI though indicated all studies as moderately or highly sensitive, revealed certain strengths and weaknesses of variable study designs ([Table 7](#t7){ref-type="table"}). While the objectives of the studies, selection criteria and orthodontic mechanics were generally clear, they strikingly lacked sample size calculation with only one study indicating the same.^9^ The authors took 5 as the sample size for inclusion, based on statistician's advice. Randomization of experimental teeth/ side / patients falling into study and control group have been clearly stated in only 21 out of 48 studies, suggesting substantial bias in all studies. The present SR deals with biomarker evaluation in GCF, hence the GCF handling characteristics have been adequate in all studies. However, the specification of time, temperature and humidity at the time of GCF collection was a major shortfall, with only four studies mentioning it. The statistical significance of the results, wherever applicable, have been stated in all the studies, but none of the studies mentioned dropouts or confounders, which might influence the results.

Table 7Results of quality assessment of 48 studies for inclusion of studies in the reviewS. No.Criteria (29)ResponseYesNoUnclearI. Study design (18)1.Objective: objective clearly formulated48\--2.Sample size: considered adequate2-463.Spectrum of patients representative of patients receiving the test in practice48\--4.Ethical clearance mentioned408-5.Selection criteria: clearly described48\--6.Randomization: stated2127-7.Baseline characteristics: clearly defined471-8.Control: clearly defined46-29.Orthodontic mechanics explained in sufficient detail to permit replication of experiment451210.Orthodontic force: clearly specified3512111.Description of execution of index test: sufficient to permit replication of test45-312Absence of time difference between index test & control: mentioned3612-13.Index test executed at specified time and environmental conditions444-14.Use of proper indices for assessment of gingival & periodontal status (Pre-treatment)408-15.Use of proper indices for assessment of gingival & periodontal status (at each observation time)1729216.Oral hygiene regime-mentioned3231317.Prophylaxis done (Pre-treatment)3414-18.Prophylaxis done(at each observation time)1137-II. Study measurements (3)1.GCF handling characteristics: explained47-12.Measurement method: appropriate to the objective48\--3.Reliability-adequate level of agreement48-III. Statistical analysis (5)1.Dropouts: dropouts included in data analysis147-2.Statistical analysis: appropriate for data48-3.Confounders: confounders included in analysis-48-4.Statistical significance level: P value stated48\--5.Confidence intervals provided48\--IV. Study results and conclusions (3)1.Index test compared to baseline482.Index test compared to control483.Conclusions: specific408[^8]

Despite the various shortcomings noticed in the study designs, the current evidence has generated ample evidence related to enzymes in OTM and has also opened new arena for future research in this direction.

Perhaps a most exciting area of research will involve biological basis of tooth movement with different ligation modes of brackets. Further studies could be conducted with LDH as marker for high frictional resistance in different combinations of brackets and wires, as only single study in this SR found no significant change in LDH in initial OTM with self-ligating brackets and superelastic or thermoactive archwire. Another split-mouth study correlating biomarker level with microbial colonization in different ligation modes showed a significantly greater level of AST in arch wire ligation than self-ligation, associated with greater microbial count.

An interesting correlation of MPO with pain was established with an early increase in MPO within 2hr of force application, coinciding with initial pain incidence in orthodontic patients. βG has been explored for its association with the most suitable wires for alignment and could be explored further in different types and magnitudes of forces.

Based on similarity between peri-implant fluid (PIMF) and GCF, the mediators studied in GCF could also be evaluated in PICF to assess stability of contemporary orthodontic anchorage devices, micro-implants, as has been suggested by study of interleukin 1β in PIMF.[@B80]

Despite the heterogeneity in study design and categories of enzymes studied in literature, this SR provides an essential overview of the mechanism by which enzymes play a role in bone apposition, resorption as well as ECM degradation. The current SR also correlates mediator levels in GCF with phases of OTM at different magnitudes and types of forces and also ligation modes. It goes a step further in suggesting the potential areas of research in this field, based on individual studies designed for associations of mediator levels with ideal orthodontic force magnitudes, method of ligation and periodontal status, thus setting a direct implication in clinical practice.

CONCLUSIONS
===========

Orthodontic force induces change in levels of multiple enzymes detectable in GCF. These are: a) cytoplasmic enzymes released in extracellular environment after cell lysis (LDH, AST), b) Inflammatory markers released from PMNs (MPO, βG), c) enzymes involved in bone and tissue remodelling by bone resorption (TRAP, ACP), d) bone apposition (ALP) or dissolution of organic matrix (Cp, Cys, tPA, PAI) and e) various categories of MMPs responsible for degradation of ECM (MMP1, 2, 3, 8, 9, 13).Compression sites showed early increase in levels of MMP1, MMP2, TIMP1, MMP9 between 1-4hr, and late peak in TIMP2, TRAP, AST after 7d, 4-5wk and 8-12wk, respectively.Tension sites showed significant increase in ALP after 7d, MMP1 between 1-3hr and TIMP 1 and 2 levels at 4hr, 7d and 42d.Distinction between TS and CS could be made with levels of TRAP, AST, LDH, MMP9, being greater on CS than TS, and ALP greater on TS.ALP, TRAP levels were greater in 150g force than 100g force. An early rise in AST levels was seen in 150g force at 3 and 4wk, as compared to 100g force at 4 and 5 wk.Mechanical stress with continuous force of NiTi spring causes increase in MMPs 1, 3 in 24hr in CS and of ALP as early as 7d in TS.No significant association between levels of MMP-9 or AST and growth status could be established as adult and adolescents, gave no significant difference in levels.
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[^3]: \*Index test: Refers to collection of GCF at each observation interval in treatment teeth.

[^4]: A-article, f-force, t/o-type of, mc-mechanics, md/mc-mode of mechanics, tm- time, a-appliance, re-reactivation, to-total, du-duration, n-number, ob-observation, B-baseline, min- minutes, g- grams, Ir- Interrupted, Cn- Continuous, Im- intermittent, Rt-retraction, sg-segmented, sp-spring, Ech-elastomeric chain, NiTi-nitinol, c-control, NM-not mentioned, y-year, d-day, m-month, h-hour, lv-levelling, se-separator, ac-activated, HG-headgear, NHG-non-headgear, bu-buccal, la-labial, RME-rapid maxillary expansion, HR-hybrid retractor, RCD- rapid canine distaliser, Sa-Sample, M/F-male/female, E- enzyme, Me- mediator, T-tooth, sc-specification, rn-randomisation, ml-malocclussion, HS-Handsearched, P-Pubmed, S-Scopus, GS- Google scholar, N-No, Y-yes, Mx-Maxilla, Md-Mandible, H-history, ls-loss, gv-gingival, if-inflammation, PD-probing depth, wk-week, R-right, L-left, C-canine, PM-premolar, Mo-molar, CI-central incisor, I-incisor, Ag- Antagonistic, ct- Contralateral, ip-interproximal, op-opposing, Ex- Experimental, c- Control, aj-adjacent, Exs-Experimental site1, Ec- Extraction, Ms- Mesial, D- Distal, rq-required, q-quadrant, OTM-orthodontic tooth movement, sf- surface, ado-adolescent, AST-aspartate transaminase, TRAP-Acid phosphatase, ALP-Alkaline Phosphatase, βG- beta glucuronidase, MMP-matrix metalloproteinase, LDH-lactate dehydrogenase, Cp-Cathepsin, MPO- myeloperoxidase, CK-creatinine, NO-Nitric oxide, IL-Interleukin, CRP- C Reactive Protein, hm-humidity, sc-specification, ins-insertion, MB-Mesio-buccal, ML-Mesio-lingual, DP-Disto-palatal, DB- Disto-buccal, df-differentiation, gp-group, cmp-compression, kPa-kilopascal, mx-maximum, gw-growth, Oc-osteoclast, Ix- Index, Bu Tp-buccal tipping, C-canine, Clf-cleft, I-incisor, NA-not applicable, wk-week, crw-crowding, minm-minimum, bimax-bimaxillary, wi-wire, lig-ligature, Ad-adult, RANKL-receptor antagonist nuclear kappa ligand, OPG-osteoprotegerin, IL-\_1RA-interleukin 1 receptor antagonist, therm-thermoplastic, t-PA-plasminogen, TNFα-tumour necrosis factor, TIMP-Tissue inhibitor metalloproteinase, MCP- Methyl-accepting chemotaxis protein, MPO-myeloperoxidase, ortho-orthodontic, cys-cysteine, cN-centinewton, TSP-thrombospondin 1, NGAL-neutrophil gelatinase-associated lipocalin, ACP-acyl carrier protein, CS-chondroitin sulphate, GM-CSF- Granulocyte-macrophage colony-stimulating factor, IFNγ-Interferon gamma, MIP-Macrophage inflammatory protein, βG-beta globulin, PAI-plasminogen activator inhibitor, EGF-Epidermal growth factor, dst-distalisation, Intr-intrusion, aln-alignment, cst-constriction, AL-after loading, BL-before loading, Mx constr- Maxillary constriction, Exp- Expansion, Hyr- Hyrax, LB-laceback, TB-Tie back, SE-superelastic NiTi, HANT- heat-activated NiTi, MSSS- multistranded stainless steel.

[^5]: A-article, Mw-mouth wash, fq/o-frequency of, d-day, px-prophyaxis, t/t-treatment, ob-observation, po-point, asm-assessment, gv-gingival, pd-periodontal, in-inflammation, cx glu-chlorhexidine gluconate, Y-yes, NM-not mentioned, N-no, h-hour, Benz HCL-benzydamine hydrochloride, wk-week, hy-hygiene, instr-instructions,motiv-motivation.

[^6]: A-article, tp-temperature, hm-humidity, mt/o-method of, cl-collection, sp-specification,i ns-insertion, mm-millimeter, du/o-duration of, rep-repeated, i/o-interval of, st-storage, al-analysis, pr-protein, cc-concentration, NM-Not Mentioned, N-No, Y- Yes, PP- Periopaper, PT- Periotron, WB- Western Blot, ELISA- Enzyme linked immunos orbent assay, IA- Immunoassay, RIA- Radio IA, meas-measurement, pg-picogram, µg-microgram, ml-millilitre, µL-microlitre, GCF-gingival crevicular fluid, tot-total, g-gram, ng-nanogram, s-second, min- minutes, ^0^C-degree Celsius, SP-spectrophotometery, Ar-array, As-assay, mb-multiplex bead, LMAT-Luminex multianalyte techonology, QAK- Quantibody Ar kit, end PP-endodontic paperstrip, FP- Filter paper strips, µP-micropippete, IU-international units, L-litre, LDH-lactate dehydrogenase, AST-aspartate transaminase, TRAP-Acid phosphatase, ALP- Alkaline Phospahatase, PMNs -polymorphonucleosides, Cp -cathepsin, Cys -cysteine, Tot -total, pmol -picomol, flr-flurometery, QA- Quantibody assay, PNPP kin- para nitrophenyl phosphate kinetic, pp- paper point.

[^7]: A -article, sts -statistically, al -analysis, ap -applied, cf -confounders, rg -regulation, Pk -peak, sd -secondary, oc -outcome, cr -correlation, sn -significant, Y -yes, N -no, NM -not mentioned, inc -increase, dec -decrease, fluct -fluctuated, h -hour, mon -month, d-day, wk-week, tot -total, prot -protein, conc -concentration, mg -milligram, ml -millilitre, g -gram, \> -greater than, VAS -visual analogue scale, C-canine, mov-movement, b/w-between, cn-continuous, &-and, F-force, Asc-associated, gen-genetic, GCF-gingival crevicular fluid, compd-compared, B-baseline, IL -interleukin, ΒG-beta glucoronidase, TNFα-tumour necrosis factor alpha, SD-short duration, LD-long duration, HG-, RDG-, Diff-difference, vol-volume, Rt-retraction, if-inflammation, Avg-average, cyt-cytokine, chemo-chemokine, kwn-known, MOP, PI-plaque index, BOP-bleeding on probing, Exp-experimental, c-control, Avg-average, Mx-maxilla, ct-contralateral, differen-differentiation, se-separator, gp-group, cmp-compression, tn- tension, kPa-kilopascal, max-maximum, gw-growth, T-tooth, Oc-osteoclast, RDG- Rapid canine distalisation group, HG- hybrid reactor group, Rt- retraction, Aa-Actinobacillus, rd-reading, wi-wire, lig-ligature, Ad-adult, RANKL-receptor antagonist nuclear kappa ligand, OPG-osteoprotegerin, IL-1RA-interleukin 1 receptor antagonist, therm-thermoplastic, t-PA-plasminogen, TIMP-Tissue inhibitor metalloproteinase, MPO-myeloperoxidase, ortho-orthodontic, cys-cysteine, TSP-thrombospondin 1, NGAL-neutrophil gelatinase-associated lipocalin, GM-CSF-Granulocyte-macrophage colony-stimulating factor, Niti-nitinol, Cp-Cathepsin, Cys-cysteine, Ix-Index, T-tooth, MMP-matrix metalloproteinase, TRAP-Acid phosphatase, ALP-Alkaline Phosphatase, Ms-mesial, D-distal, si-site, Lvl-level, lig-ligation, ACP-acyl carrier protein, PM-premolar, Mo-molar, CI-central incisor, vol-volume, AST-aspartate transaminase, crw-crowding, minm-minimum, ado-adolescent, rec-rectangular, OTM-orthodontic tooth movement, AL-after loading, TT-test tooth, b/w-between, enz-enzyme, Ix-index, pl-plaque, scr-score, Bac-bacterial, PD- probing depth, PL-supragingival plaque, actv- activity, actvn- activation, compl-completion, reactivation-reactvn, SE-superelastic NiTi, HANT- heat-activated NiTi, MSSS- multistranded stainless steel, vol-volume.

[^8]: \*Index test: Refers to collection of GCF at each observation interval in treatment teeth.
